alexa Nano- And Submicro-sized Mesoporous Silica Particles With Tunable Size And Porosity As Perspective Biopharmaceutically Active Excipients
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

9th Annual European Pharma Congress
June 26-28, 2017 Madrid, Spain

Katerina O Filatova and Vladimir Sedlarik
UTB in Zlin, Czech Republic
Posters & Accepted Abstracts: Pharmaceut Reg Affairs
DOI: 10.4172/2167-7689-C1-025
Abstract
Conventional development in an understanding of the reasons of diseases with a deepening of knowledge in pharmacokinetic mechanisms allows developing modern dosage forms for the effective, safe and reliable application of bioactive compounds at the targeted site of action within a desirable time and duration. Unfortunately, current excipients cannot meet all the requirements to the modern pharmaceutical formulations and mostly play a role of fillers. However, an active ingredient is just one part of the medicine administered to the patient and it is the formulation of the drug and an excipient that translates drug properties into clinical effect. It is shown that dosage forms engineered using the nano- and submicro-scaled excipients have an additional functionality and can control a pharmacological effect of a drug. Nanomaterials as active excipients not only improve pharmacokinetic of cargo molecules but also increase their solubility and permeability, which is of great importance because just nearly 25% of all pharmaceutically active compounds are recognized as highly soluble and permeable, while the rest of them has either/or low solubility and permeability or even both of them simultaneously with other disadvantages (very short or very long shelf-life, poor adsorption through GIT). In the sight of aforementioned a concept of therapeutic treatment is realized in a development of silica-based nanomaterials that maintain drug concentration in GIT at a desired value as long as possible, i.e. they are able to exert a control on the drug release rate and duration, for further pharmaceutical implementation as an active excipient in solid dosage forms. Silica-based submicro- and nanoparticles were prepared using a template sol-gel approach in the presence of cationic and nonionic surfactants. Methotrexate was loaded into silica-based mesoporous materials with different textural properties. An amount of the drug loaded and an in vitro release kinetics were revealed as a function of the pore size of the materials. Release of methotrexate from synthesized carriers in comparison with the release from the commercially available pharmaceutical form mimicking an oral administration was investigated. It was turned out that silica-based materials exhibit control release kinetic with the absence of a burst effect, while the later one is considerably worst in an adjustment of controllable in-vitro pharmacokinetic of a drug. Mesoporous materials with a wide range of size (25-1000 nm) and variable textural characteristics were obtained that allowed to adapt different synthetic routs for further use as the perspective reservoirs for carrying in pharmaceutical means. Further development of the pharmaceutical forms on the basis of silica-based nano- and submicro-materials will ensure that a drug will be available at the desired site within the required time and duration. Those materials can serve as substituents of current fillers in pharmaceutical formulations.
Biography

Katerina O Filatova has completed her Master’s in 2009 from VNMU Pyrogov b.n., Pharmaceutical Faculty. Currently, she is studying Doctoral program at the Technological Faculty at the TBU in Zlin, Czech Republic.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords